Publicacións (15) Publicacións de María Luz Pellón Augusto

filter_list

2024

  1. Real-world effectiveness and safety of trifluridine-tipiracil (FTD/TPI) and bevacizumab (BEV) in refractory metastatic colorectal cancer (mCRC): The BeTAS trial.

    Journal of Clinical Oncology, Vol. 42, Núm. 3_suppl, pp. 51-51

2022

  1. P-122 Vitamin D-based score in gastric cancer

    Annals of Oncology, Vol. 33, pp. S293

2021

  1. Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method

    Healthcare (Switzerland), Vol. 9, Núm. 6

  2. Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer

    Journal of B.U.ON., Vol. 26, Núm. 5, pp. 2131-2140

  3. Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain

    BMC Cancer, Vol. 21, Núm. 1

2020

  1. Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359

  2. First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study

    Journal of Geriatric Oncology, Vol. 11, Núm. 8, pp. 1263-1267

  3. P-123 Outcomes and predictive factors of regorafenib benefit in patients with metastatic colorectal cancer in a real-life setting

    Annals of Oncology, Vol. 31, pp. S130

  4. P-43 Ramucirumab effectiveness in patients with advanced gastric cancer or gastro-esophageal junction adenocarcinoma in clinical practice in Spain: Sub-analysis of RAMIS study

    Annals of Oncology, Vol. 31, pp. S103

2019

  1. Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen

    Annals of Oncology, Vol. 30, pp. iv42-iv43

  2. Is there any affordable and reliable score in local gastric cancer?

    Annals of Oncology, Vol. 30, pp. iv60

2018

  1. Differences in outcome according to chemotherapy backbone and maintenance treatment in HER2 positive metastatic gastric cancer (GC) or gastroesophageal junction (GEJ)

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii225

2017

  1. Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention

    Clinical and Translational Oncology, Vol. 19, Núm. 9, pp. 1067-1078

2016

  1. Foliculitis en una mujer tratada con trastuzumab emtansina

    Piel, Vol. 31, Núm. 4, pp. 297-299

2006

  1. Urgencias relacionadas con complicaciones del cáncer

    Manual básico de urgencias (Fundación Profesor Novoa Santos), pp. 483-488